Loading...
Projects / Programmes source: ARIS

Socio-economic consequences of cancer from the perspective of the individual and society including the impact of COVID-19 pandemic

Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   

Code Science Field
3.02  Medical and Health Sciences  Clinical medicine 
Keywords
cancer; cancer incidence; oncology; costs; financial distress; financial toxicity; cancer burden; COVID-19; overall survival; disease outcome; health related quality of life; public health system; employment; vocational rehabilitation; work retention; career; retirement; economy; public finance
Evaluation (metodology)
source: COBISS
Points
9,778.03
A''
500.29
A'
3,078.33
A1/2
5,175.85
CI10
46,909
CImax
10,695
h10
62
A1
30.22
A3
16
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024
Data for ARIS tenders ( 04.04.2019 – Programme tender, archive )
Database Linked records Citations Pure citations Average pure citations
WoS  663  32,085  28,714  43.31 
Scopus  669  39,776  35,984  53.79 
Organisations (2) , Researchers (23)
0302  Institute of Oncology Ljubljana
no. Code Name and surname Research area Role Period No. of publicationsNo. of publications
1.  50451  Mitja Anžič  Medical sciences  Researcher  2022 - 2025 
2.  33070  PhD Jasna But Hadžič  Medical sciences  Researcher  2022 - 2025  155 
3.  14575  PhD Maja Čemažar  Oncology  Researcher  2022 - 2025  1,546 
4.  34770  PhD Danijela Golo  Medical sciences  Researcher  2022 - 2025  16 
5.  53935  Maja Ivanetič Pantar  Medical sciences  Researcher  2022 - 2025  65 
6.  54214  Ana Mihor  Medical sciences  Researcher  2023 - 2025  66 
7.  39125  MSc Miha Oražem  Medical sciences  Researcher  2022 - 2025  95 
8.  26530  PhD Andraž Perhavec  Medical sciences  Researcher  2022 - 2025  156 
9.  34883  PhD Ivica Ratoša  Medical sciences  Head  2022 - 2025  200 
10.  33071  PhD Ajra Šečerov Ermenc  Medical sciences  Researcher  2022 - 2025  88 
11.  30641  PhD Sonja Tomšič  Public health (occupational safety)  Researcher  2022 - 2025  219 
12.  23050  PhD Vesna Zadnik  Public health (occupational safety)  Researcher  2022 - 2025  558 
13.  21953  PhD Helena Barbara Zobec Logar  Oncology  Researcher  2022 - 2025  110 
0584  University of Ljubljana, School of Economics and Business (SEB)
no. Code Name and surname Research area Role Period No. of publicationsNo. of publications
1.  19759  PhD Mojca Bavdaž  Economics  Researcher  2022 - 2025  258 
2.  23012  PhD Petra Došenović Bonča  Economics  Researcher  2022 - 2025  567 
3.  53492  PhD Eva Erjavec  Economics  Researcher  2024 - 2025  35 
4.  30715  PhD Daša Farčnik  Economics  Researcher  2022 - 2024  202 
5.  37675  PhD Tanja Istenič  Economics  Researcher  2022 - 2025  189 
6.  24102  PhD Črt Kostevc  Economics  Researcher  2022 - 2025  333 
7.  23027  PhD Nina Ponikvar  Economics  Researcher  2023 - 2025  302 
8.  57562  Sara Ražman  Economics  Researcher  2023 - 2025 
9.  23031  PhD Tjaša Redek  Economics  Researcher  2022 - 2025  840 
10.  55136  Tomaž Ulčakar    Technical associate  2022 - 2023  59 
Abstract
Cancer is a major public health concern in Slovenia. The total prevalence of patients with cancer in Slovenia is predicted to rise substantially due to rising incidence and improved treatment outcomes. Patients with cancer are being cured at an increasing rate, but they are being handicapped in their everyday lives by the repercussions of the disease and/or therapy, which influence physical, emotional, and social well-being, as well as vocational rehabilitation. Cancer has significant socioeconomic effects at the individual and societal levels, which are understudied in Slovenia. The diagnosis of cancer affects the financial situation of an individual with cancer, including his/her family and not only through the costs incurred because of illness and its treatment not covered by health insurance, but also through the loss of income because of sick leave, job loss and career decline. Living with cancer usually results in long periods of sick leave due to treatment and functional impairment. Patients with cancer experience both subjective financial concerns as well as objective financial consequences of cancer, for which the term financial toxicity was coined. Financial toxicity is associated with several clinically relevant disease outcomes, namely health related quality of life, disease symptoms, treatment compliance and survival. It depends on many factors such as employment and marital status, type of cancer, gender and income. The extent of financial toxicity due to cancer in Slovenian patients is unknown, nor is its impact on disease outcomes and quality of life. Cancer has significant direct costs for the industry and public finances. The data show that the direct burden of cancer is increasing due to the cost of treatment and has doubled in Europe between 1995 and 2018. Expenditure on sick leave and pensions, which are linked to health reasons for retirement is also increasing. These trends will affect Slovenia even more than other countries, as it is one of the three countries in the EU with the fastest aging population. In addition, the proportion of cohorts in the population over the age of 50 is expected to increase over the next years. An interdisciplinary research project focuses on the socio-economic consequences of cancer assessed at three levels: individual (patients, families, and informal carers), firm (employers), and macroeconomic (health care, public finances, and broader socioeconomic aspects). A special emphasis will be placed on the immediate and long-term implications of the 2019 coronavirus pandemic (COVID-19) on cancer burden. The project's content is grounded in medicine (oncology), since the starting point is an analysis of cancer incidence, and the objective is to reduce the burden inflicted by cancer on individuals and society. It focuses on identifying the burden of cancer for the individual and the family through an analysis of the impact of cancer on the individual's career path and well-being (including material well-being), and is thus related to the long-term goals of decent work and inequality, as the project will reveal possible differences in well-being due to the burden of cancer, resulting in increased inequality. The project will also point out the differences in the burden of cancer by gender and the consequences for career development by gender. Due to the calculations of the burden on companies and public finances, the project relies heavily on topics covered in the context of business development, industry, and economic growth. In 2020, the COVID-19 outbreak shook the economy as well as healthcare systems all around the world. The treatment and comprehensive management of patients with cancer has also been disrupted. Therefore, one of the project’s goals will be also a comprehensive analysis of the long-term socio-economic consequences of delays in cancer diagnoses and treatment due to COVID-19 pandemic.
Views history
Favourite